Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine after PCI in coronary artery disease patients with hypertensive left ventricular hypertrophy
ChiCTR1800017876Phase 4Recruiting
- Sponsor
- Sir Run-Run Shaw Hospital
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of trimetazidine in coronary arteriosclerosis and hypertensive left ventricular hypertrophy (LVH) (2 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoint: left ventricular mass index. Started Sep 2018; status: recruiting.
02
Drugs
trimetazidine
03
Conditions
coronary arteriosclerosishypertensive left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on ChiCTR1800017876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017876.